Subscribe to RSS

DOI: 10.1055/s-0045-1814741
Photodynamic Therapy for Head and Neck Cancers: A Review of a Novel, Patient-Friendly Solution and Prospects
Authors
Funding and Sponsorship This study was funded by the MATCH grant fund of the Ministry of Higher Education Malaysia (MOHE), project code 203.PPSP.6782007.
Abstract
Background
Head and neck cancers (HNCs) are among the six most common malignancies worldwide, with incidence projected to increase substantially by 2030. Although surgery and chemoradiation remain effective standard treatments, they are often costly, less accessible, and associated with significant functional and aesthetic morbidity. Photodynamic therapy (PDT) has emerged as a promising alternative due to its safety profile, cost-effectiveness, and ability to preserve vital structures.
Materials and Methods
This narrative review examined preclinical and clinical studies evaluating PDT for HNC. A structured literature search was conducted in PubMed, Scopus, and Web of Science using terms such as “photodynamic therapy,” “head and neck cancer,” “oral squamous cell carcinoma,” “minimally invasive therapy,” “photoimmunotherapy,” “photochemical internalization,” and “nanoparticle delivery.” Only English-language, peer-reviewed articles reporting on the efficacy, safety, or mechanisms of PDT were included. Eligible studies were selected based on relevance to clinical application and innovation, and findings were organized thematically to highlight therapeutic outcomes, patient-centered advantages, and translational developments supporting broader clinical integration.
Findings
PDT demonstrates several key advantages over conventional treatments, including high tumor specificity, reduced toxicity, preservation of normal tissues, and suitability for outpatient care. These benefits are especially valuable in low-resource settings. PDT also supports better functional and aesthetic outcomes by minimizing scarring and reducing hospital stays. Its compatibility with other modalities, such as chemotherapy, radiotherapy, and immunotherapy, further enhances its role in multimodal treatment strategies. Technological progress, particularly in nanoparticle-based photosensitizers and targeted light delivery, has markedly improved the precision and effectiveness of PDT.
Conclusion
PDT holds strong potential as a safe, accessible, and cost-effective treatment for HNCs. Its favorable therapeutic profile, combined with expanding technological innovations, positions PDT as an important and increasingly relevant option within future oncologic care.
Keywords
minimally invasive therapy - targeted cancer treatment - nanoparticle therapy - photochemical internalization - photoimmunotherapy - salvage therapyAuthors' Contributions
N.M.L. had the original idea for the article and developed the review concept. A.M.B. performed the literature search and drafted the initial manuscript. Z.I.M.I., S.E.T.S., T.A.D.A.A.T.D., N.M., S.A., C.F., and N.M.L. critically revised the work for important intellectual content. All the authors read and approved the final version of the manuscript.
Compliance with Ethical Principles
Not applicable.
Publication History
Article published online:
31 December 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Bray F, Laversanne M, Sung H. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74 (03) 229-263
- 2 Kang H(T), Kennedy TA, Yu E. Head and neck squamous cell cancer: approach to staging and surveillance. In: Hodler J, Kubik-Huch RA, Roos JE. eds. Diseases of the Brain, Head and Neck, Spine 2024–2027: Diagnostic Imaging. Cham: Springer; 2024: 251-264
- 3 Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers 2020; 6 (01) 92
- 4 Pfister DG, Spencer S, Adelstein D. et al. Head and neck cancers, version 2.2020. J Natl Compr Canc Netw 2020; 18 (07) 873-898
- 5 Peng W, de Bruijn HS, Ten Hagen TLM. et al. Targeted photodynamic therapy of human head and neck squamous cell carcinoma with anti-epidermal growth factor receptor antibody cetuximab and photosensitizer IR700DX in the mouse skin-fold window chamber model. Photochem Photobiol 2020; 96 (03) 708-717
- 6 Rigual NR, Thankappan K, Cooper M. et al. Photodynamic therapy for head and neck dysplasia and cancer. Arch Otolaryngol Head Neck Surg 2009; 135 (08) 784-788
- 7 Kwiatkowski S, Knap B, Przystupski D. et al. Photodynamic therapy: mechanisms, photosensitizers and combinations. Biomed Pharmacother 2018; 106: 1098-1107
- 8 Agostinis P, Berg K, Cengel KA. et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011; 61 (04) 250-281
- 9 Zuluaga MF, Lange N. Combination of photodynamic therapy with anti-cancer agents. Curr Med Chem 2008; 15 (17) 1655-1673
- 10 O'Connor AE, Gallagher WM, Byrne AT. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 2009; 85 (05) 1053-1074
- 11 Dave D, Desai U, Despande N. Photodynamic therapy: a view through light. J Orofac Res 2012; 2: 82-86
- 12 Allison RR, Huang Z, Dallimore I, Moghissi K. Tools of clinical photodynamic therapy (PDT): a mini compendium. Photodiagnosis Photodyn Ther 2024; 46: 104058
- 13 Kim MM, Darafsheh A. Light sources and dosimetry techniques for photodynamic therapy. Photochem Photobiol 2020; 96 (02) 280-294
- 14 Gunaydin G, Gedik ME, Ayan S. Photodynamic therapy for the treatment and diagnosis of cancer: a review of the current clinical status. Front Chem 2021; 9: 686303
- 15 D'Cruz AK, Robinson MH, Biel MA. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck 2004; 26 (03) 232-240
- 16 Vidujith AVA, Jayasinghe CD, De Costa MDP, Senthilnithy R. Photodynamic therapy: an overview and insights into a prospective mainstream anticancer therapy. J Turkish Chem Soc Sect Chem 2022; 9 (03) 821-848
- 17 Sarafoleanu C, Vuzitas A, Manea C. Difficulties in the surgical management of head and neck cancer patient. Rom J Rhinol 2017; 7 (27) 153-161
- 18 Embring A, Onjukka E, Mercke C, Lax I, Berglund A, Friesland S. Dose escalation of oropharyngeal cancer: long-time follow-up and side effects. Cancers (Basel) 2023; 15 (09) 2580
- 19 Stubblefield MD. Clinical evaluation and management of radiation fibrosis syndrome. Phys Med Rehabil Clin N Am 2017; 28 (01) 89-100
- 20 Lou PJ, Jäger HR, Jones L, Theodossy T, Bown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer 2004; 91 (03) 441-446
- 21 Harréus U. Surgical errors and risks: the head and neck cancer patient. GMS Curr Top Otorhinolaryngol Head Neck Surg 2013; 12: Doc04
- 22 Stoker SD, Indrasari SR, Herdini C. et al. Photodynamic therapy as salvage therapy for patients with nasopharyngeal carcinoma experiencing local failures following definitive radiotherapy. Photodiagnosis Photodyn Ther 2015; 12 (03) 519-525
- 23 Singh MN, Kinhikar RA, Agarwal JP, Laskar SG. Principles and practice of radiation oncology. In: Kataki AC, Barmon D. eds. Fundamentals in Gynaecologic Malignancy. Singapore: Springer; 2022: 99-117
- 24 Melissant HC, Jansen F, Eerenstein SE. et al. Body image distress in head and neck cancer patients: what are we looking at?. Support Care Cancer 2021; 29 (04) 2161-2169
- 25 Ronen O, Robbins KT, Shaha AR. et al. Emerging concepts impacting head and neck cancer surgery morbidity. Oncol Ther 2023; 11 (01) 1-13
- 26 Brook I. Early side effects of radiation treatment for head and neck cancer. Cancer Radiother 2021; 25 (05) 507-513
- 27 Brook I. Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J 2020; 38 (02) 84-92
- 28 Wright KE, Liniker E, Loizidou M, Moore C, Macrobert AJ, Phillips JB. Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model. Br J Cancer 2009; 101 (04) 658-665
- 29 Kübler AC, Stenzel W, Rühling M, Meul B, Fischer JH. Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves. Lasers Surg Med 2003; 33 (04) 247-255
- 30 Grant WE, Speight PM, MacRobert AJ, Hopper C, Bown SG. Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br J Cancer 1994; 70 (01) 72-78
- 31 Lou PJ, Jäger HR, Jones L, Theodossy T, Bown SG, Hopper C. Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer. Br J Cancer 2004; 91 (03) 441-446
- 32 Rigual NR, Thankappan K, Cooper M. et al. Photodynamic therapy for head and neck dysplasia and cancer. Arch Otolaryngol Head Neck Surg 2009; 135 (08) 784-788
- 33 Rigual NR, Shafirstein G, Frustino J. et al. Adjuvant intraoperative photodynamic therapy in head and neck cancer. JAMA Otolaryngol Head Neck Surg 2013; 139 (07) 706-711
- 34 The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41 (10) 1403-1409
- 35 Tonsbeek AM, Hundepool CA, Roubos J. et al. Quality of life in 583 head and neck cancer survivors assessed with the FACE-Q head and neck cancer module. Oral Oncol 2024; 153: 106813
- 36 Jerjes W, Stevenson H, Ramsay D, Hamdoon Z, Hopper C. Quality of life following photodynamic therapy for head and neck pathologies: an exploratory study. Photodiagnosis Photodyn Ther 2022; 38: 102800
- 37 Hung TM, Lin CR, Chi YC. et al. Body image in head and neck cancer patients treated with radiotherapy: the impact of surgical procedures. Health Qual Life Outcomes 2017; 15 (01) 165
- 38 Karakullukcu B, van Oudenaarde K, Copper MP. et al. Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients. Eur Arch Otorhinolaryngol 2011; 268 (02) 281-288
- 39 Abbas S, Jerjes W, Upile T, Vaz F, Hopper C. The palliative role of PDT in recurrent advanced nasopharyngeal carcinoma: case series. Photodiagnosis Photodyn Ther 2012; 9 (02) 142-147
- 40 Kübler A, Niziol C, Sidhu M, Dünne A, Werner JA. Analysis of cost effectiveness of photodynamic therapy with Foscan (Foscan-PDT) in comparison with palliative chemotherapy in patients with advanced head-neck tumors in Germany. Laryngorhinootologie 2005; 84 (10) 725-732
- 41 Hopper C, Niziol C, Sidhu M. The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncol 2004; 40 (04) 372-382
- 42 Kato H, Okunaka T, Tsuchida T, Shibuya H, Fujino S, Ogawa K. Analysis of the cost-effectiveness of photodynamic therapy in early stage lung cancer. Diagn Ther Endosc 1999; 6 (01) 9-16
- 43 Cerrati EW, Nguyen SA, Farrar JD, Lentsch EJ. The efficacy of photodynamic therapy in the treatment of oral squamous cell carcinoma: a meta-analysis. Ear Nose Throat J 2015; 94 (02) 72-79
- 44 Gondivkar SM, Gadbail AR, Choudhary MG, Vedpathak PR, Likhitkar MS. Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: a systematic review. J Investig Clin Dent 2018; 9 (01) e12270
- 45 Liu W, Zhang X, Shen X, Liu L. Evaluating photodynamic therapy for oral precancerous lesions: highlighting outcome measure of malignant transformation. J Dent Sci 2024; 19 (01) 631-636
- 46 Jiang W, Liang M, Lei Q, Li G, Wu S. The current status of photodynamic therapy in cancer treatment. Cancers (Basel) 2023; 15 (03) 585
- 47 van Doeveren TEM, Karakullukçu MB, van Veen RLP, Lopez-Yurda M, Schreuder WH, Tan IB. Adjuvant photodynamic therapy in head and neck cancer after tumor-positive resection margins. Laryngoscope 2018; 128 (03) 657-663
- 48 Vander Poorten V, Meulemans J, Nuyts S. et al. Postoperative photodynamic therapy as a new adjuvant treatment after robot-assisted salvage surgery of recurrent squamous cell carcinoma of the base of tongue. World J Surg Oncol 2015; 13 (01) 214
- 49 Santos LL, Oliveira J, Monteiro E, Santos J, Sarmento C. Treatment of head and neck cancer with photodynamic therapy with redaporfin: a clinical case report. Case Rep Oncol 2018; 11 (03) 769-776
- 50 Wang X, Li N, Meng J, Wen N. The use of topical ALA-photodynamic therapy combined with induction chemotherapy for locally advanced oral squamous cell carcinoma. Am J Otolaryngol 2021; 42 (06) 103112
- 51 Hopper C, Tan B, Hasan T. et al. Developing world applications of PDT in head and neck cancer (conference presentation). In: Hasan T. ed. 17th International Photodynamic Association World Congress. Vol. 11070. Bellingham, WA: SPIE; 2019. :110703U
- 52 Petrucci B, Okerosi S, Patterson RH. et al. The global otolaryngology-head and neck surgery workforce. JAMA Otolaryngol Head Neck Surg 2023; 149 (10) 904-911
- 53 Patterson RH, Fischman VG, Wasserman I. et al. Global burden of head and neck cancer: economic consequences, health, and the role of surgery. Otolaryngol Head Neck Surg 2020; 162 (03) 296-303
- 54 Gollnick S, Anton K. Development of a registry for patients treated with photodynamic therapy (conference presentation). In: Kessel DH, Hasan T. eds. Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVII. Vol. 10476. Bellingham, WA: SPIE; 2018: 104760M
- 55 Souho T, Lamboni L, Xiao L, Yang G. Cancer hallmarks and malignancy features: gateway for improved targeted drug delivery. Biotechnol Adv 2018; 36 (07) 1928-1945
- 56 Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 2015; 93: 52-79
- 57 Dai X, Yu L, Zhao X, Ostrikov KK. Nanomaterials for oncotherapies targeting the hallmarks of cancer. Nanotechnology 2020; 31 (39) 392001
- 58 Lee D, Kwon S, Jang SY, Park E, Lee Y, Koo H. Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles. Bioact Mater 2021; 8: 20-34
- 59 Huang L, Asghar S, Zhu T. et al. Advances in chlorin-based photodynamic therapy with nanoparticle delivery system for cancer treatment. Expert Opin Drug Deliv 2021; 18 (10) 1473-1500
- 60 Hong EJ, Choi DG, Shim MS. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials. Acta Pharm Sin B 2016; 6 (04) 297-307
- 61 Itoo AM, Paul M, Padaga SG, Ghosh B, Biswas S. Nanotherapeutic intervention in photodynamic therapy for cancer. ACS Omega 2022; 7 (50) 45882-45909
- 62 dos Santos AF, Arini GS, de Almeida DRQ, Labriola L. Nanophotosensitizers for cancer therapy: a promising technology?. JPhys Mater 2021; 4 (03) 034013
- 63 Wang D, Fei B, Halig LV. et al. Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer. ACS Nano 2014; 8 (07) 6620-6632
- 64 Jerjes W, Theodossiou TA, Hirschberg H. et al; From Basic Mechanisms to Clinical Research. Photochemical internalization for intracellular drug delivery: from basic mechanisms to clinical research. J Clin Med 2020; 9 (02) 528
- 65 O'Rourke C, Hopper C, MacRobert AJ, Phillips JB, Woodhams JH. Could clinical photochemical internalisation be optimised to avoid neuronal toxicity?. Int J Pharm 2017; 528 (1–2): 133-143
- 66 Sultan AA, Jerjes W, Berg K. et al. Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial. Lancet Oncol 2016; 17 (09) 1217-1229
- 67 Nguyen A, Bhandari C, Keown M. et al. Increasing the dye payload of cetuximab-IRDye800CW enables photodynamic therapy. Mol Pharm 2024; 21 (07) 3296-3309
- 68 Cognetti DM, Johnson JM, Curry JM. et al. Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma. Head Neck 2021; 43 (12) 3875-3887
- 69 Cognetti DM, Curry JM, Johnson J. et al. Safety and efficacy findings from a phase Ib/II study of ASP-1929 photoimmunotherapy with pembrolizumab in recurrent and/or metastatic head and neck squamous cell carcinoma. Head Neck 2025; 47 (01) 1-15
- 70 Lorenz KJ, Maier H. Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients. Eur Arch Otorhinolaryngol 2009; 266 (12) 1937-1944
- 71 Schweitzer VG. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med 2001; 29 (04) 305-313
- 72 Ikeda H, Ohba S, Egashira K, Asahina I. The effect of photodynamic therapy with talaporfin sodium, a second-generation photosensitizer, on oral squamous cell carcinoma: a series of eight cases. Photodiagnosis Photodyn Ther 2018; 21: 176-180
- 73 Ikeda H, Tobita T, Ohba S, Uehara M, Asahina I. Treatment outcome of Photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia. Photodiagnosis Photodyn Ther 2013; 10 (03) 229-235
- 74 Kübler AC, de Carpentier J, Hopper C, Leonard AG, Putnam G. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy. Int J Oral Maxillofac Surg 2001; 30 (06) 504-509
- 75 Toratani S, Tani R, Kanda T, Koizumi K, Yoshioka Y, Okamoto T. Photodynamic therapy using Photofrin and excimer dye laser treatment for superficial oral squamous cell carcinomas with long-term follow up. Photodiagnosis Photodyn Ther 2016; 14: 104-110
- 76 Biel MA. Photodynamic therapy treatment of early oral and laryngeal cancers. Photochem Photobiol 2007; 83 (05) 1063-1068
- 77 Jerjes W, Upile T, Alexander Mosse C. et al. Prospective evaluation of 110 patients following ultrasound-guided photodynamic therapy for deep seated pathologies. Photodiagnosis Photodyn Ther 2011; 8 (04) 297-306
- 78 Hosokawa S, Takahashi G, Sugiyama KI. et al. Porfimer sodium-mediated photodynamic therapy in patients with head and neck squamous cell carcinoma. Photodiagnosis Photodyn Ther 2020; 29: 101627
- 79 Hopper C, Kübler A, Lewis H, Tan IB, Putnam G. mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. Int J Cancer 2004; 111 (01) 138-146
- 80 Tan IB, Dolivet G, Ceruse P, Vander Poorten V, Roest G, Rauschning W. Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study. Head Neck 2010; 32 (12) 1597-1604
- 81 Carvalho AL, Salvajoli JV, Kowalski LP. A comparison of radiotherapy or radiochemotherapy with symptomatic treatment alone in patients with advanced head and neck carcinomas. Eur Arch Otorhinolaryngol 2000; 257 (03) 164-167
